News
2d
Zacks Investment Research on MSNMedtronic (MDT) Gains As Market Dips: What You Should KnowIn the latest trading session, Medtronic (MDT) closed at $88.58, marking a +1.04% move from the previous day. This change outpaced the S&P 500's 0.07% loss on the day. Elsewhere, the Dow saw a ...
Hosted on MSN1mon
Medtronic to Separate Diabetes Business - MSNMedical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently returned to ...
Medtronic races for market share in fast-growing treatment of irregular heartbeats With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market ...
News National business Medtronic ventilators helped save lives during the pandemic, so why is the company shutting down the business? March 17, 2025 Updated Mon., March 17, 2025 at 12:04 p.m.
Medtronic said Wednesday it plans to separate its diabetes business, which generates more than $2.8 billion in annual sales, into a new publicly traded company.
Medtronic, a global healthcare technology company, announced that MiniMed is the name for the planned new diabetes company following the intended separation. The name honors the company's roots ...
Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit ...
And one of Martha’s imprints is the marriage of mission and performance. “My job and our leadership team’s job is to keep reminding our employees that we’ve got to be an ‘and’ company ...
Medtronic will use Nvidia AI technology to detect precancerous tissue earlier -- and improve patient outcomes. The medical device giant sees AI as the key to personalized medicine. This portfolio ...
Earnings Results Medtronic’s stock drops on inventory hiccup and revenue miss Medtronic’s adjusted third-quarter profit tops analyst estimates but its surgical-products revenue dips on ...
STAT spoke to Medtronic CEO Geoff Martha about the company’s challenges in the diabetes and renal denervation markets, as well as his broader vision for teasing out innovative products.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results